(3aR,8aR)-(-)-4,4,8,8-四(3,5-二异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-间二氧杂环戊烯并[4,5-e]二氧膦

1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin, 4,4,8,8-tetrakis[3,5-bis(1-methylethyl)phenyl]tetrahydro-2,2-dimethyl-6-phenyl-, (3aS,8aS)-

产品编号.: A371274 CAS号: 1422371-27-4
分子式: C61H81O4P 分子量: 909.267
纯度: 98% MDL NO.:

中文名称:(3aR,8aR)-(-)-4,4,8,8-四(3,5-二异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-间二氧杂环戊烯并[4,5-e]二氧膦
CAS号:1422371-27-4
中文别名:(3aR,8aR)-(-)-4,4,8,8-四(3,5-二异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-间二氧杂环戊烯并[4,5-e]二氧膦;(3AS,8AS)-(-)-4,4,8,8-四(3,5-二异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧杂[4,5-E]二氧杂磷酸酯;(3AS,8AS)-4,4,8,8 -四[3,5-双(1-甲基乙基)苯基]四氢-2,2-二甲基-6-苯基-1,3-二氧杂环戊烯并[4,5-E] [1,3,2]二氧磷;(3AS,8AS)-(+)-4,4,8,8-四(3,5-二-异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧杂环戊烯并[4,5-E]二氧杂磷杂环庚烷;(3AR,8AR)-(-)-4,4,8,8-四(3,5-二异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-间二氧杂环戊烯并[4,5-E]二氧膦
英文名称:1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin, 4,4,8,8-tetrakis[3,5-bis(1-methylethyl)phenyl]tetrahydro-2,2-dimethyl-6-phenyl-, (3aS,8aS)-
英文别名:1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin, 4,4,8,8-tetrakis[3,5-bis(1-methylethyl)phenyl]tetrahydro-2,2-dimethyl-6-phenyl-, (3aS,8aS)-;(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin;(3aS,8aS)-4,4,8,8-Tetrakis[3,5-bis(1-methylethyl)phenyl]tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin;(3AS,8AS)-(+)-4,4,8,8-TETRAKIS(3,5-DI-I-PROPYLPHENYL)TETRAHYDRO-2,2-DIMETHYL-6-PHENYL-1,3-DIOXOLO[4;(3aS,8aS)-4,4,8,8-tetrakis(3,5-diisopropylphenyl)-2,2-dimethyl-6-phenyl-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine;CS-0035153;1422371-27-4;E78751;(3aS,8aS)-4,4,8,8-tetrakis[3,5-di(propan-2-yl)phenyl]-2,2-dimethyl-6-phenyl-3a,8a-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine;MFCD23704800
EINEC:
分子式:C61H81O4P
分子量:909.267
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

(3aR,8aR)-(-)-4,4,8,8-四(3,5-二异丙基苯基)四氢-2,2-二甲基-6-苯基-1,3-间二氧杂环戊烯并[4,5-e]二氧膦
1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin, 4,4,8,8-tetrakis[3,5-bis(1-methylethyl)phenyl]tetrahydro-2,2-dimethyl-6-phenyl-, (3aS,8aS)-;(3aS,8aS)-(+)-4,4,8,8-Tetrakis(3,5-di-i-propylphenyl)tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin;(3aS,8aS)-4,4,8,8-Tetrakis[3,5-bis(1-methylethyl)phenyl]tetrahydro-2,2-dimethyl-6-phenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin;(3AS,8AS)-(+)-4,4,8,8-TETRAKIS(3,5-DI-I-PROPYLPHENYL)TETRAHYDRO-2,2-DIMETHYL-6-PHENYL-1,3-DIOXOLO[4;(3aS,8aS)-4,4,8,8-tetrakis(3,5-diisopropylphenyl)-2,2-dimethyl-6-phenyl-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine;CS-0035153;1422371-27-4;E78751;(3aS,8aS)-4,4,8,8-tetrakis[3,5-di(propan-2-yl)phenyl]-2,2-dimethyl-6-phenyl-3a,8a-dihydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepine;MFCD23704800